AZIYO BIOLOGICS INC's ticker is AZYO and the CUSIP is 05479K106. A total of 19 filers reported holding AZIYO BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $799,769 | -41.0% | 188,181 | 0.0% | 0.03% | -47.4% |
| Q3 2022 | $1,355,000 | +1.9% | 188,181 | 0.0% | 0.06% | +14.0% |
| Q2 2022 | $1,330,000 | +18.8% | 188,181 | 0.0% | 0.05% | +47.1% |
| Q1 2022 | $1,120,000 | -9.2% | 188,181 | -3.9% | 0.03% | 0.0% |
| Q4 2021 | $1,234,000 | -9.4% | 195,809 | 0.0% | 0.03% | -10.5% |
| Q3 2021 | $1,362,000 | -27.6% | 195,809 | 0.0% | 0.04% | -13.6% |
| Q2 2021 | $1,882,000 | -3.7% | 195,809 | +38.5% | 0.04% | 0.0% |
| Q1 2021 | $1,954,000 | – | 141,395 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 1,655,184 | $2,499 | 1.96% |
| PERKINS CAPITAL MANAGEMENT INC | 275,329 | $416 | 0.39% |
| Prosight Management, LP | 196,443 | $296,629 | 0.14% |
| Indie Asset Partners, LLC | 26,500 | $40,015 | 0.05% |
| Knollwood Investment Advisory, LLC | 58,962 | $89,033 | 0.02% |
| Alyeska Investment Group, L.P. | 214,343 | $323,658 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,134 | $8 | 0.00% |
| US BANCORP \DE\ | 625 | $944 | 0.00% |
| WELLS FARGO & COMPANY/MN | 56 | $85 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |